PDB Short entry for 1F95 HEADER CONTRACTILE PROTEIN/PEPTIDE 07-JUL-00 1F95 TITLE SOLUTION STRUCTURE OF DYNEIN LIGHT CHAIN 8 (DLC8) AND BIM PEPTIDE TITLE 2 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: DYNEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: 8KDA LIGHT CHAIN; COMPND 5 SYNONYM: PROTEIN INHIBITOR OF NEURONAL NITRIC OXIDE SYNTHASE, DLC8; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: BCL2-LIKE 11 (APOPTOSIS FACILITATOR); COMPND 9 CHAIN: C, D; COMPND 10 FRAGMENT: DLC8 BINDING REGION; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET14B; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 OTHER_DETAILS: THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED. THIS SOURCE 12 SEQUENCE OCCURS NATURALLY IN HUMANS (HOMO SAPIENS) KEYWDS DYNEIN, LIGHT CHAIN, DLC8, BIM, APOPTOSIS, CONTRACTILE PROTEIN- KEYWDS 2 PEPTIDE COMPLEX EXPDTA SOLUTION NMR AUTHOR J.-S.FAN,Q.ZHANG,H.TOCHIO,M.LI,M.ZHANG REVDAT 4 13-JUL-11 1F95 1 VERSN REVDAT 3 24-FEB-09 1F95 1 VERSN REVDAT 2 01-APR-03 1F95 1 JRNL REVDAT 1 28-FEB-01 1F95 0 JRNL AUTH J.FAN,Q.ZHANG,H.TOCHIO,M.LI,M.ZHANG JRNL TITL STRUCTURAL BASIS OF DIVERSE SEQUENCE-DEPENDENT TARGET JRNL TITL 2 RECOGNITION BY THE 8 KDA DYNEIN LIGHT CHAIN. JRNL REF J.MOL.BIOL. V. 306 97 2001 JRNL REFN ISSN 0022-2836 JRNL PMID 11178896 JRNL DOI 10.1006/JMBI.2000.4374 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-KUNSTLEVE, REMARK 3 JIANG,KUSZEWSKI,NILGES,PANNU,READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1F95 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-AUG-00. REMARK 100 THE RCSB ID CODE IS RCSB011396. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 100MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.5MM DLC8/BIM PEPTIDE COMPLEX REMARK 210 15N; 100MM PHOSPHATE BUFFER; 10MM REMARK 210 DTT; 90% H2O AND 10% D2O; 1.5MM REMARK 210 DLC8/BIM PEPTIDE COMPLEX 15N,13C; REMARK 210 100MM PHOSPHATE BUFFER; 10MM DTT; REMARK 210 90% H2O AND 10% D2O; 1.5MM DLC8/ REMARK 210 BIM PEPTIDE COMPLEX ; 100MM REMARK 210 PHOSPHATE BUFFER; 10MM DTT; 99.9% REMARK 210 D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; 3D_13C- REMARK 210 SEPARATED_NOESY; 2D NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 750 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : VNMR 6.1B, NMRPIPE 1.7, X-PLOR REMARK 210 3.8 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O THR A 70 HD1 HIS A 72 1.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 3 -138.71 43.23 REMARK 500 ASP A 12 70.07 -150.07 REMARK 500 ASN A 33 32.22 -94.37 REMARK 500 ASN A 51 141.02 84.33 REMARK 500 ASN A 61 134.47 -171.16 REMARK 500 PHE A 62 -170.98 179.20 REMARK 500 GLU A 69 -122.79 -85.28 REMARK 500 GLN A 80 -26.80 82.68 REMARK 500 PHE A 86 140.38 -177.11 REMARK 500 SER A 88 43.45 -154.62 REMARK 500 CYS B 2 46.01 -177.92 REMARK 500 ARG B 4 130.12 -177.02 REMARK 500 VAL B 7 66.53 -156.82 REMARK 500 ASN B 10 144.42 -174.84 REMARK 500 ASN B 51 139.94 78.46 REMARK 500 PHE B 62 144.79 178.35 REMARK 500 HIS B 68 -169.85 -128.93 REMARK 500 GLU B 69 -125.65 -81.95 REMARK 500 GLN B 80 42.73 -90.37 REMARK 500 PHE B 86 141.95 -178.50 REMARK 500 SER B 88 44.78 -153.31 REMARK 500 CYS C 3 145.60 174.73 REMARK 500 SER D 2 112.56 -169.09 REMARK 500 CYS D 3 127.50 -170.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF BCL2-LIKE 11 REMARK 800 (APOPTOSIS FACILITATOR) REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF BCL2-LIKE 11 REMARK 800 (APOPTOSIS FACILITATOR) REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1F3C RELATED DB: PDB REMARK 900 THIS IS A SOLUTION STRUCTURE OF DYNEIN LIGHT CHAIN 8 (DLC8) REMARK 900 COMPLEXED WITH ONE TARGET, BIM. DBREF 1F95 A 1 89 UNP P63170 DYL1_RAT 1 89 DBREF 1F95 B 1 89 UNP P63170 DYL1_RAT 1 89 DBREF 1F95 C 1 9 UNP O43521 B2L11_HUMAN 108 116 DBREF 1F95 D 1 9 UNP O43521 B2L11_HUMAN 108 116 SEQRES 1 A 89 MET CYS ASP ARG LYS ALA VAL ILE LYS ASN ALA ASP MET SEQRES 2 A 89 SER GLU GLU MET GLN GLN ASP SER VAL GLU CYS ALA THR SEQRES 3 A 89 GLN ALA LEU GLU LYS TYR ASN ILE GLU LYS ASP ILE ALA SEQRES 4 A 89 ALA HIS ILE LYS LYS GLU PHE ASP LYS LYS TYR ASN PRO SEQRES 5 A 89 THR TRP HIS CYS ILE VAL GLY ARG ASN PHE GLY SER TYR SEQRES 6 A 89 VAL THR HIS GLU THR LYS HIS PHE ILE TYR PHE TYR LEU SEQRES 7 A 89 GLY GLN VAL ALA ILE LEU LEU PHE LYS SER GLY SEQRES 1 B 89 MET CYS ASP ARG LYS ALA VAL ILE LYS ASN ALA ASP MET SEQRES 2 B 89 SER GLU GLU MET GLN GLN ASP SER VAL GLU CYS ALA THR SEQRES 3 B 89 GLN ALA LEU GLU LYS TYR ASN ILE GLU LYS ASP ILE ALA SEQRES 4 B 89 ALA HIS ILE LYS LYS GLU PHE ASP LYS LYS TYR ASN PRO SEQRES 5 B 89 THR TRP HIS CYS ILE VAL GLY ARG ASN PHE GLY SER TYR SEQRES 6 B 89 VAL THR HIS GLU THR LYS HIS PHE ILE TYR PHE TYR LEU SEQRES 7 B 89 GLY GLN VAL ALA ILE LEU LEU PHE LYS SER GLY SEQRES 1 C 9 MET SER CYS ASP LYS SER THR GLN THR SEQRES 1 D 9 MET SER CYS ASP LYS SER THR GLN THR HELIX 1 1 SER A 14 TYR A 32 1 19 HELIX 2 2 ILE A 34 TYR A 50 1 17 HELIX 3 3 SER B 14 TYR B 32 1 19 HELIX 4 4 ILE B 34 TYR B 50 1 17 SHEET 1 A 5 ALA A 6 MET A 13 0 SHEET 2 A 5 HIS A 72 LEU A 78 -1 O PHE A 73 N ASP A 12 SHEET 3 A 5 VAL A 81 LYS A 87 -1 O VAL A 81 N LEU A 78 SHEET 4 A 5 TRP A 54 VAL A 66 -1 N HIS A 55 O PHE A 86 SHEET 5 A 5 LYS C 5 GLN C 8 -1 N LYS C 5 O VAL A 66 SHEET 6 A 5 TRP A 54 VAL A 66 0 SHEET 7 A 5 TRP B 54 HIS B 68 -1 N CYS B 56 O TYR A 65 SHEET 8 A 5 VAL B 81 LYS B 87 -1 N ALA B 82 O GLY B 59 SHEET 9 A 5 HIS B 72 LEU B 78 -1 O HIS B 72 N LYS B 87 SHEET 10 A 5 ALA B 6 MET B 13 -1 O VAL B 7 N TYR B 77 SHEET 11 A 5 TRP A 54 VAL A 66 0 SHEET 12 A 5 LYS C 5 GLN C 8 -1 N LYS C 5 O VAL A 66 SHEET 13 A 5 TRP B 54 HIS B 68 0 SHEET 14 A 5 CYS D 3 GLN D 8 -1 O CYS D 3 N HIS B 68 CISPEP 1 PRO A 52 THR A 53 0 0.80 CISPEP 2 PRO B 52 THR B 53 0 0.54 SITE 1 AC1 16 ASN A 61 PHE A 62 GLY A 63 SER A 64 SITE 2 AC1 16 TYR A 65 VAL A 66 THR A 67 HIS A 68 SITE 3 AC1 16 GLU A 69 THR A 70 PHE A 73 TYR A 75 SITE 4 AC1 16 TYR A 77 ALA A 82 LEU A 84 LYS B 36 SITE 1 AC2 18 ILE A 34 GLU A 35 LYS A 36 ASN B 10 SITE 2 AC2 18 GLY B 59 ASN B 61 PHE B 62 GLY B 63 SITE 3 AC2 18 SER B 64 TYR B 65 VAL B 66 THR B 67 SITE 4 AC2 18 HIS B 68 GLU B 69 THR B 70 TYR B 75 SITE 5 AC2 18 ALA B 82 LEU B 84 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000